We are available to help treat the full picture, including: Type 2 diabetes High blood pressure Hormonal factors Stress and lifestyle contributors Our goal is long-term health, not quick fixes
Change in pharmacodynamic variables following once-weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono substudy)
213 KoikeHItoKTakezawaYOyamaTYamanakaHSuzukiK
Given that obesity and hypertension frequently coexist and together substantially increase cardiovascular and kidney risk, these findings support obesity treatment as an important component of blood pressure management and cardiovascular risk reduction, said lead researcher Marcel Muskiet, MD, PhD, an internist, endocrinologist, and vascular medicine specialist in the Department of Medicine at Leiden University Medical Center (LUMC) in the Netherlands
12, 2019, pp
FuturHealth offers one of the most accessible and affordable GLP-1 programs by removing insurance barriers, providing flat-rate pricing, and enabling fast onboarding